{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:21:06Z","timestamp":1768717266051,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Third Affiliated Hospital of Sun Yat-Sen University, Clinical Research Program and the Natural Science Foundation of Guangdong Province, China","award":["20180220701 and 2018A030313489"],"award-info":[{"award-number":["20180220701 and 2018A030313489"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic syndrome (Mets) is commonly seen in bipolar disorder (BD). As the key component and early biological index of Mets, insulin resistance (IR) among BD has received more and more attention. However, little is known about the prevalence of IR and its associated factors in drug-na\u00efve patients with (BD), especially among Han Chinese population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted on 125 drug-na\u00efve patients with bipolar disorder (BD) and 85 healthy controls (HC). The Homeostatic Model Assessment of insulin resistance (HOMA-IR) was calculated, and IR was defined as HOMA-IR greater than the 75th percentile value for health controls (2.35). Clinical characteristics of BD were collected through semi-structural interview performed by a trained interviewer with background of psychiatric education.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the measured anthropocentric variables including BMI, waist circumference, abdomen circumference, hipline, and hip-waist ratio, waist circumference was found to be the most closely related to IR (0R\u2009=\u20091.070, 95%CI\u2009=\u20091.031\u20131.110, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Male was another factor that was associated with IR (OR\u2009=\u20092.281, 95%CI\u2009=\u20091.107\u20134.702, <jats:italic>P<\/jats:italic>\u2009=\u20090.025). After adjusted for gender and waist circumference, the risk of IR was significantly higher in bipolar disorder than in healthy controls (OR\u2009=\u20092.66, 95%CI\u2009=\u20091.364\u20135.214, <jats:italic>P<\/jats:italic>\u2009=\u20090.004). No significant association was found between IR and any of the observed physical and mental comorbidities, any characteristic of illness course including age onset, number of mixed episodes, types of current state, duration of current episode, duration of illness course, rapid cycling, number of mood episodes, and subgroup of BD. Hypersomnia was the only symptomatic feature that was significantly associated with IR (OR\u2009=\u20090.316, 95%CI\u2009=\u20090.124\u20130.803, <jats:italic>P<\/jats:italic>\u2009=\u20090.016).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Bipolar disorder increases two-to-three-fold risk of IR, both circumference and male are the risk factors of IR but hypersomnia act as a protective factor.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05838-5","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T09:02:30Z","timestamp":1716454950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of insulin resistance and its associated factors in drug-na\u00efve patients with bipolar disorder among Han Chinese population"],"prefix":"10.1186","volume":"24","author":[{"given":"Kanglai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youzhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"11","key":"5838_CR1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.4088\/JCP.14r09635","volume":"76","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D, Mitchell AJ, De Hert M, Sienaert P, Probst M, Buys R, Stubbs B. Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis. J Clin Psychiatry. 2015;76(11):1490\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"5838_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10401230590932380","volume":"17","author":"RS McIntyre","year":"2005","unstructured":"McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005;17(2):83\u201393.","journal-title":"Ann Clin Psychiatry"},{"key":"5838_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jad.2021.08.139","volume":"295","author":"MP Schuster","year":"2021","unstructured":"Schuster MP, Borkent J, Chrispijn M, Ioannou M, Doornbos B, Burger H, Haarman BCM. Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study. J Affect Disord. 2021;295:1161\u20138.","journal-title":"J Affect Disord"},{"issue":"1","key":"5838_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40345-019-0142-3","volume":"7","author":"K Coello","year":"2019","unstructured":"Coello K, Vinberg M, Knop FK, Pedersen BK, McIntyre RS, Kessing LV, Munkholm K. Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Int J Bipolar Disord. 2019;7(1):8.","journal-title":"Int J Bipolar Disord"},{"issue":"5\u20136","key":"5838_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/07853890.2019.1659511","volume":"51","author":"CV Calkin","year":"2019","unstructured":"Calkin CV. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Ann Med. 2019;51(5\u20136):281\u201393.","journal-title":"Ann Med"},{"issue":"9","key":"5838_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","volume":"70","author":"C Crump","year":"2013","unstructured":"Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013;70(9):931\u20139.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"5838_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","volume":"206","author":"M Alda","year":"2015","unstructured":"Alda M, Calkin CV, Garnham JS, Hajek T, O\u2019Donovan MC, Ruzickova M, Slaney CM, Uher R. Insulin resistance and outcome in bipolar disorder. Br J Psychiatry. 2015;206(1):52\u20137.","journal-title":"Br J Psychiatry"},{"key":"5838_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jad.2016.02.002","volume":"195","author":"RB Mansur","year":"2016","unstructured":"Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, et al. Impaired glucose metabolism moderates the course of illness in bipolar disorder. J Affect Disord. 2016;195:57\u201362.","journal-title":"J Affect Disord"},{"issue":"7","key":"5838_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/070674370304800705","volume":"48","author":"M Ruzickova","year":"2003","unstructured":"Ruzickova M, Slaney C, Garnham J, Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry. 2003;48(7):458\u201361.","journal-title":"Can J Psychiatry"},{"key":"5838_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2018.10.360","volume":"245","author":"L Steardo Jr","year":"2019","unstructured":"Steardo L Jr., Fabrazzo M, Sampogna G, Monteleone AM, D\u2019Agostino G, Monteleone P, Maj M. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments. J Affect Disord. 2019;245:174\u20139.","journal-title":"J Affect Disord"},{"key":"5838_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpsychires.2018.03.006","volume":"102","author":"K Cairns","year":"2018","unstructured":"Cairns K, McCarvill T, Ruzickova M, Calkin CV. Course of bipolar illness worsens after onset of insulin resistance. J Psychiatr Res. 2018;102:34\u20137.","journal-title":"J Psychiatr Res"},{"key":"5838_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jad.2020.01.145","volume":"266","author":"V Salvi","year":"2020","unstructured":"Salvi V, Di Salvo G, Kor\u010d\u00e1kov\u00e1 J, Torriero S, Aragno E, Koleni\u010d M, Ungrmanov\u00e1 M, Maina G, Mencacci C, Hajek T. Insulin resistance is associated with verbal memory impairment in bipolar disorders. J Affect Disord. 2020;266:610\u20134.","journal-title":"J Affect Disord"},{"key":"5838_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jad.2015.03.041","volume":"179","author":"CC Bortolasci","year":"2015","unstructured":"Bortolasci CC, Vargas HO, Vargas Nunes SO, de Melo LG, de Castro MR, Moreira EG, Dodd S, Barbosa DS, Berk M, Maes M. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. J Affect Disord. 2015;179:148\u201355.","journal-title":"J Affect Disord"},{"issue":"1","key":"5838_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12291-012-0292-x","volume":"29","author":"P Guha","year":"2014","unstructured":"Guha P, Bhowmick K, Mazumder P, Ghosal M, Chakraborty I, Burman P. Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder. Indian J Clin Biochem. 2014;29(1):51\u20136.","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"5838_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/070674371005500605","volume":"55","author":"V Taylor","year":"2010","unstructured":"Taylor V, McKinnon MC, Macdonald K, Jaswal G, Macqueen GM. Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment. Can J Psychiatry. 2010;55(6):362\u20138.","journal-title":"Can J Psychiatry"},{"issue":"7","key":"5838_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/bdi.12633","volume":"20","author":"LR Wulsin","year":"2018","unstructured":"Wulsin LR, Blom TJ, Durling M, Welge JA, DelBello MP, Adler CM, McNamara RK, Strakowski SM. Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder. Bipolar Disord. 2018;20(7):658\u201365.","journal-title":"Bipolar Disord"},{"key":"5838_CR17","doi-asserted-by":"crossref","unstructured":"Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Atypical antipsychotics and metabolic syndrome: from Molecular mechanisms to clinical differences. Pharmaceuticals (Basel) 2021, 14(3).","DOI":"10.3390\/ph14030238"},{"issue":"2","key":"5838_CR18","first-page":"e22021","volume":"14","author":"W Mohammed","year":"2022","unstructured":"Mohammed W, Al Naeem W. Prevalence and management of metabolic syndrome in Adult Psychiatric patients receiving second-generation antipsychotics at Sheikh Khalifa Medical City. Cureus. 2022;14(2):e22021.","journal-title":"Cureus"},{"issue":"4","key":"5838_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.metabol.2005.10.005","volume":"55","author":"A Onat","year":"2006","unstructured":"Onat A, Hergenc G, Turkmen S, Yazici M, Sari I, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism. 2006;55(4):445\u201352.","journal-title":"Metabolism"},{"issue":"1","key":"5838_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/07853890500415358","volume":"38","author":"E Ferrannini","year":"2006","unstructured":"Ferrannini E. Is insulin resistance the cause of the metabolic syndrome? Ann Med. 2006;38(1):42\u201351.","journal-title":"Ann Med"},{"issue":"3","key":"5838_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"5838_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","volume":"94","author":"LP van der Heide","year":"2005","unstructured":"van der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GM. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem. 2005;94(4):1158\u201366.","journal-title":"J Neurochem"},{"issue":"2","key":"5838_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00702-004-0163-6","volume":"112","author":"SJ Kim","year":"2005","unstructured":"Kim SJ, Han Y. Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (akt). J Neural Transm (Vienna). 2005;112(2):179\u201391.","journal-title":"J Neural Transm (Vienna)"},{"issue":"Pt A","key":"5838_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.01.014","volume":"74","author":"G Morris","year":"2017","unstructured":"Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017;74(Pt A):1\u201320.","journal-title":"Neurosci Biobehav Rev"},{"key":"5838_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2023.04.068","volume":"334","author":"A Miola","year":"2023","unstructured":"Miola A, Alvarez-Villalobos NA, Ruiz-Hernandez FG, De Filippis E, Veldic M, Prieto ML, Singh B, Sanchez Ruiz JA, Nunez NA, Resendez MG, et al. Insulin resistance in bipolar disorder: a systematic review of illness course and clinical correlates. J Affect Disord. 2023;334:1\u201311.","journal-title":"J Affect Disord"},{"issue":"1","key":"5838_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5838_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429\u201335.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"5838_CR28","first-page":"7","volume":"13","author":"E So","year":"2003","unstructured":"So E, Kam I, Leung C, Chung D, Liu Z, Fong S. The chinese-bilingual SCID-I\/P project: stage 1\u2013reliability for mood disorders and schizophrenia. Hong Kong J Psychiatry. 2003;13(1):7\u201319.","journal-title":"Hong Kong J Psychiatry"},{"issue":"1","key":"5838_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jhn.12278","volume":"29","author":"AM Madden","year":"2016","unstructured":"Madden AM, Smith S. Body composition and morphological assessment of nutritional status in adults: a review of anthropometric variables. J Hum Nutr Diet. 2016;29(1):7\u201325.","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"5838_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/diacare.24.2.362","volume":"24","author":"A Katsuki","year":"2001","unstructured":"Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24(2):362\u20135.","journal-title":"Diabetes Care"},{"issue":"6","key":"5838_CR31","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"7","key":"5838_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"5838_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","volume":"6","author":"EB Geer","year":"2009","unstructured":"Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6(Suppl 1):60\u201375.","journal-title":"Gend Med"},{"issue":"3","key":"5838_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/187152511797037547","volume":"9","author":"G Banos","year":"2011","unstructured":"Banos G, Guarner V, Perez-Torres I. Sex steroid hormones, cardiovascular diseases and the metabolic syndrome. Cardiovasc Hematol Agents Med Chem. 2011;9(3):137\u201346.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"11","key":"5838_CR35","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/jech.2007.068460","volume":"62","author":"C Hadley","year":"2008","unstructured":"Hadley C, Tegegn A, Tessema F, Cowan JA, Asefa M, Galea S. Food insecurity, stressful life events and symptoms of anxiety and depression in east Africa: evidence from the Gilgel Gibe growth and development study. J Epidemiol Community Health. 2008;62(11):980\u20136.","journal-title":"J Epidemiol Community Health"},{"key":"5838_CR36","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Manent JI, Jover AM, Martinez CS, Tom\u00e1s-Gil P, Mart\u00ed-Lliteras P, L\u00f3pez-Gonz\u00e1lez. \u00c1 A: Waist circumference is an essential factor in Predicting insulin resistance and early detection of metabolic syndrome in adults. Nutrients 2023, 15(2).","DOI":"10.3390\/nu15020257"},{"issue":"3","key":"5838_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"5838_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/diabetes.52.1.172","volume":"52","author":"DJ Nieves","year":"2003","unstructured":"Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52(1):172\u20139.","journal-title":"Diabetes"},{"issue":"12","key":"5838_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11892-021-01430-3","volume":"21","author":"A Petrelli","year":"2021","unstructured":"Petrelli A, Giovenzana A, Insalaco V, Phillips BE, Pietropaolo M, Giannoukakis N. Autoimmune inflammation and insulin resistance: Hallmarks so far and yet so close to explain diabetes endotypes. Curr Diab Rep. 2021;21(12):54.","journal-title":"Curr Diab Rep"},{"key":"5838_CR40","doi-asserted-by":"publisher","first-page":"110307","DOI":"10.1016\/j.mce.2018.10.005","volume":"497","author":"A Ilyas","year":"2019","unstructured":"Ilyas A, H\u00fcbel C, Stahl D, Stadler M, Ismail K, Breen G, Treasure J, Kan C. The metabolic underpinning of eating disorders: a systematic review and meta-analysis of insulin sensitivity. Mol Cell Endocrinol. 2019;497:110307.","journal-title":"Mol Cell Endocrinol"},{"issue":"0","key":"5838_CR41","first-page":"1245","volume":"70","author":"N Matulewicz","year":"2016","unstructured":"Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online). 2016;70(0):1245\u201358.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"2","key":"5838_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.genhosppsych.2012.10.004","volume":"35","author":"U ALBERT","year":"2013","unstructured":"ALBERT U, AGUGLIA A, CHIARLE A, BOGETTO F, MAINA G. Metabolic syndrome and obsessive\u2015compulsive disorder: a naturalistic Italian study. Gen Hosp Psychiatry. 2013;35(2):154\u20139.","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"5838_CR43","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s10865-022-00356-9","volume":"45","author":"AL Shell","year":"2022","unstructured":"Shell AL, Williams MK, Patel JS, Vrany EA, Considine RV, Acton AJ, Stewart JC. Associations of somatic depressive symptoms with body mass index, systemic inflammation, and insulin resistance in primary care patients with depression. J Behav Med. 2022;45(6):882\u201393.","journal-title":"J Behav Med"},{"key":"5838_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euroneuro.2023.03.007","volume":"71","author":"WR Chae","year":"2023","unstructured":"Chae WR, Baumert J, N\u00fcbel J, Brasanac J, Gold SM, Hapke U, Otte C. Associations between individual depressive symptoms and immunometabolic characteristics in major depression. Eur Neuropsychopharmacol. 2023;71:25\u201340.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"5838_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamapsychiatry.2014.411","volume":"71","author":"AM Lasserre","year":"2014","unstructured":"Lasserre AM, Glaus J, Vandeleur CL, Marques-Vidal P, Vaucher J, Bastardot F, Waeber G, Vollenweider P, Preisig M. Depression with atypical features and increase in obesity, body Mass Index, Waist circumference, and Fat Mass: a prospective, Population-based study. JAMA Psychiatry. 2014;71(8):880\u20138.","journal-title":"JAMA Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05838-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:04:19Z","timestamp":1716458659000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05838-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5838"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05838-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"24 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the study was approved by the Clinical Research Ethics Committee of the Third Affiliated Hospital of Sun Yat-Sen University (approval number: [2017]02-233-01). Written informed consents were obtained from all participants. Participants who aged under 18 were required to provide written informed consent from their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}